When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
MGNX - MacroGenics updates on FDA review of margetuximab for breast cancer
MacroGenics Inc.
The FDA has notified MacroGenics (NASDAQ:MGNX) that it is no longer planning to hold an Oncologic Drugs Advisory Committee (ODAC) meeting to discuss the Biologics License Application (BLA) for margetuximab, an investigational, monoclonal antibody that targets HER2, for the treatment of patients with pre-treated metastatic HER2-positive breast cancer in combination with chemotherapy.
More news on: MacroGenics, Inc., Healthcare stocks news,